心血管疾病生物标志物的电化学生物传感方面的进展
Sakthivel Kogularasu1,2, Wan-Ching Lin3,4, Yen-Yi Lee1,2,5
1Super Micro Mass Research and Technology Center, Cheng Shiu University, Kaohsiung 833301, Taiwan. guoping@gcloud.csu.edu.tw.
Journal of materials chemistry. B
|June 24, 2024
概括
电化学生物传感为心血管疾病 (CVD) 提供了先进的诊断工具. 这项技术在改善心脏病的检测和管理方面表现有前途,解决了全球主要的健康挑战.
科学领域:
- 生物医学工程 生物医学工程
- 分析化学 分析化学
- 心脏病学 心脏病学
背景情况:
- 心血管疾病 (CVDs) 代表着一个重要的全球健康负担,具有重大的社会经济影响.
- 目前对心血管疾病的诊断方法需要改进,这推动了对电化学生物传感等创新解决方案的需求.
研究的目的:
- 提供心血管疾病的全面审查,包括其特征,风险因素和治疗方法.
- 分析用于心血管疾病诊断的电化学生物传感技术的原理,分类和组件.
- 探索电化学生物传感器在革命性心血管医疗保健方面的最新进展和未来前景.
主要方法:
- 审查有关心血管疾病和诊断工具的现有文献,重点关注心脏生物标志物.
- 深入分析电化学生物传感原理,包括识别分子和传感器.
- 检查电极架构,信号放大和微流体集成的当代进展.
主要成果:
- 电化学生物传感器在检测心血管异常方面表现出显著的熟练程度,得到实证数据和临床见解的支持.
- 关键的进步包括新的电极设计,增强的信号放大技术和与微流体系统的集成.
- 案例研究和系统评估强调了生物传感器在提高心血管疾病诊断精度方面的潜力.
结论:
- 电化学生物传感为开发心血管疾病精细诊断策略提供了一个有希望的前沿.
- 尽管存在技术性,适用性和监管方面的挑战,但生物传感器有望改变心血管医疗保健.
- 这些技术的持续发展预示着准确和可访问的心血管诊断的新时代.
更多相关视频
13:42Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
11.8K
14:53A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis
Published on: September 10, 2014
17.2K
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
137
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
137
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
77
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77
Electrocardiogram
2.3K
An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
2.3K
